Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Sleep Apnea Syndromes

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Sleep Apnea Syndromes in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.

Research Excerpts

ExcerptRelevanceReference
"The effects of DOI on the occurrence of sleep apnea were explored."1.36Effects of 5-hydroxytryptamine and 5-hydroxytryptamine 2A/2C agonist on the genioglossus activity and sleep apnea in rats. ( Wang, GF; Zhang, C; Zhong, YJ, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhong, YJ1
Zhang, C1
Wang, GF1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Sleep Apnea Syndromes

ArticleYear
Effects of 5-hydroxytryptamine and 5-hydroxytryptamine 2A/2C agonist on the genioglossus activity and sleep apnea in rats.
    Chinese medical journal, 2010, Aug-05, Volume: 123, Issue:15

    Topics: Amphetamines; Animals; Electroencephalography; Male; Rats; Rats, Sprague-Dawley; Serotonin; Serotoni

2010